INTRODUCTION
============

Porcine reproductive and respiratory syndrome (**PRRS**) is an infectious disease caused by PRRS virus (**PRRSV**) and characterized by reproductive disorders in pregnant sows and respiratory problems in pigs of various ages. The disease is presently a serious concern for the swine industry worldwide and causes a significant loss to swine producers ([@bib23]; [@bib5]). Weak initial innate immune response and inefficiency of acquired immunity greatly contribute to persistent or repeated infections in susceptible pigs and herds, and to a some extent, these weakened immune responses may predispose for secondary bacterial co-infections ([@bib17]; [@bib11]). Thus, apart from application of other methods to heighten the overall health status of the herd, use of feed ingredients or feed additives including spray-dried animal plasma, direct-fed microbials, plant extracts, and mannan oligosaccharide (**MOS**) has been suggested ([@bib36]; [@bib29]).

Products of MOS have been demonstrated to be capable of positively modulating immune responses in animals ([@bib3]; [@bib2]). However, different products extracted from the yeast cell wall may have diverse immune-related properties because each fraction differs in polymerization degree of mannan, types of terminal linkages of mannan sequences, structure, and proportion of mannan and β-glucan ([@bib42]; [@bib1]; [@bib32]). Therefore, evaluation of effect of each specific MOS product on the immune responses of the host to certain pathogens is necessary because outcome responses, such as performance and disease resistance, may be altered because of alteration of immunomodulation.

The objective of this experiment was to examine the effects of MOS (Actigen; **ACT)** on growth performance and serum concentrations of antibodies and inflammatory mediators in weanling pigs experimentally infected with PRRSV.

MATERIALS AND METHODS
=====================

The experimental protocol was approved by the University of Illinois Institutional Animal Care and Use Committee and the Institutional Biosafety Committee.

Experimental Design, Housing, and PRRSV Challenge
-------------------------------------------------

Before commencement of the experiment and PRRSV inoculation, serum samples were collected from pigs at 1 and 5 wk of age to verify if pigs were PRRSV-negative by serological and quantitative real-time reverse-transcription-PCR (**qRT-PCR**) tests. No PRRSV-specific antibodies or viruses were detected. Also, pigs were confirmed to be negative for *Mycoplasma hyopneumoniae* and swine influenza virus. A total of 32 weaned pigs \[3-wk-old; 6.3 ± 0.6 kg BW; Pig Improvement Company (**PIC**) line C-22 female × PIC line 337 male\], free of PRRSV, were transported from a University research farm to the experimental site, and upon arrival they were placed in disease-containment chambers. Each pig received a daily intramuscular injection of Lincomycin (11 mg/kg of BW; Pharmacia and Upjohn Co., Kalamazoo, MI) for 3 consecutive days after arrival to prevent infections. Pigs were blocked on the basis of initial BW within sex into 4 BW blocks, resulting in a total of 8 blocks. They were randomly assigned from within the same BW block to 1 of 4 treatments in a 2 by 2 factorial arrangement \[2 types of diet: control (0%) and ACT supplementation (0.04%); and with and without PRRSV\] in a randomized complete block design. Actigen (Alltech, Inc., Nicholasville, KY), a concentrated mannose-rich oligosaccharide fraction, was derived from the cell wall of yeast *Saccharomyces cerevisiae*. Ancestry was equalized across treatments for all measurements throughout the experimental period.

Pigs inoculated with PRRSV were housed in 1 room and those not inoculated with PRRSV were reared in the other room to avoid cross-contamination. Pigs were penned individually in disease-containment chambers with controlled temperature and a lighting regimen of 18-h light/6-h dark. Chamber temperature was maintained at 32°C for the first 2 wk after pigs arrived, then reduced 2°C each week until the temperature reached 24°C. Containment chambers were separately ventilated with negatively pressurized HEPA-filtered air. Each room contained 8 disease-containment chambers, each of which had 2 pens. A pen measured 0.6 × 1.4 m in floor area and had a plastic-coated expanded-metal floor. There was a self-feeder and nipple waterer in each pen, and pigs had access to feed and water at all times. The basal diets ([Table 1](#tbl1){ref-type="table"}) were formulated to contain all of the essential nutrients, which met or exceeded nutritional requirements of pigs ([@bib24]). Treatment diets were formulated by supplementing the basal diets with 0.04% ACT throughout the 8-wk experimental period. This supplemental amount of ACT was recommended by the manufacturer (Alltech, Inc., Nicholasville, KY).

###### 

Composition of basal diets fed to weanling pigs during the experiment (as-fed basis)^1^

                                    Phase^2^                  
  -------------------------------- ---------- ------- ------- -------
  Ingredients, %                                              
      Corn                           38.46     43.61   58.08   68.66
      Dried whey                     16.00     14.00   10.00   0.00
      Soybean meal, 48%              10.00     18.00   26.00   27.05
      Spray-dried animal plasma       6.00     3.00    0.00    0.00
      Soy protein concentrate^3^      5.00     3.00    0.00    0.00
      Select menhaden fish meal       8.58     7.04    3.12    0.00
      Soybean oil                     3.00     3.00    0.00    0.00
      Fat, choice white grease        0.00     0.00    0.00    0.94
      Lactose                         9.80     5.46    0.00    0.00
      Limestone                       0.26     0.19    0.91    1.12
      Dicalcium phosphate             0.93     1.40    0.00    0.00
      Monocalcium phosphate           0.00     0.00    0.82    1.17
      Zinc oxide                      0.42     0.42    0.00    0.00
      Mineral premix^4^               0.35     0.35    0.35    0.35
      Vitamin premix^5^               0.20     0.20    0.20    0.20
      Lysine-HCl                      0.52     0.18    0.32    0.31
      DL-Met                          0.48     0.08    0.07    0.06
      L-Thr                           0.00     0.07    0.14    0.14
  Calculated composition                                      
      ME, Mcal/kg                     3.45     3.45    3.45    3.45
      SID lysine, %                   1.50     1.45    1.30    1.15
      Ca, %                           0.90     0.90    0.80    0.80
      Available P, %                  0.55     0.55    0.40    0.40
      Lactose, %                     21.00     14.00   7.00    0.00
  Analyzed composition, %                                     
      Moisture                       11.14     10.59   12.22   14.67
      CP                             22.69     21.92   19.30   16.96
      Crude fat                       5.07     4.92    2.47    2.88
      Total dietary fiber             8.06     8.53    9.71    11.24
      NDF                             6.10     6.50    7.39    7.09
      ADF                             2.21     1.98    2.62    2.73
      Total lysine                    1.89     1.63    1.40    1.12

^1^Diets were not supplemented with antibiotics.

^2^Phase I, II, III, and IV diets were fed to pigs for 7, 7, 14, and 28 d postweaning, respectively.

^3^Soycomil, Archer Daniels Midland Company, Decatur, IL.

^4^Provided as milligrams per kilogram of diet: sodium chloride, 3,000; zinc, 100 from zinc oxide; iron, 90 from iron sulfate; manganese, 20 from manganese oxide; copper, 8 from copper sulfate; iodine, 0.35 from calcium iodide; selenium, 0.30 from sodium selenite.

^5^Provided per kilogram of diet: retinyl acetate, 2,273 μg; cholecalciferol, 17 μg; DL-α-tocopheryl acetate, 88 mg; menadione sodium bisulfate complex, 4 mg; niacin, 33 mg; D-Ca-pantothenate, 24 mg; riboflavin, 9 mg; vitamin B12, 35 μg; choline chloride, 324 mg.

After 2 wk of an 8-wk period of feeding the experimental diets, one-half of pigs were intranasally inoculated with 2 mL of a PRRSV medium containing 1 × 10^5^ 50% tissue culture infective dose. The viral strain, Purdue isolate P-129, was obtained from Indiana Animal Disease Diagnostic Laboratory (Purdue University, West Lafayette, IN). The other one-half of pigs received 2 mL of a sham medium (sterile Dulbecco\'s modified Eagle medium; Sigma-Aldrich Co., St Louis, MO). Frozen inoculums containing PRRSV were thawed and then diluted with Dulbecco\'s modified Eagle medium to contain the above challenge dose. The inoculums were kept on ice until used to challenge pigs. After PRRSV inoculation, 1 pig from the infected control treatment was culled at 18 d postinoculation (**DPI**) due to difficult breathing and severe BW loss.

Measurement of Pig Performance and Rectal Temperature
-----------------------------------------------------

Pigs were weighed at the beginning of the experiment and subsequently once every 2 wk until the end of the experiment. Feeding was manually handled and feeders were refilled with preweighed amounts of feed. Feed disappearance from each pen was determined every 2 wk from −14 to 42 DPI. The ADG, ADFI, and G:F were calculated for each pen. Rectal temperature (**RT**) was measured at 0, 3, 7, 10, and 14 DPI and subsequently weekly until 42 DPI.

Blood Sampling and Processing
-----------------------------

Pigs were sampled via venipuncture from the jugular vein to obtain blood samples at 0 (right before PRRSV inoculation), 3, and 7 DPI and subsequently weekly until 42 DPI. Ten milliliters of blood from each pig were collected into a vacutainer glass blood collection tube containing no anticoagulant. Blood was allowed to clot at room temperature for 45 min and stored overnight at 4°C before serum was harvested at room temperature by centrifugation for 10 min at 1,800 × *g*. The collected serum was aliquoted and frozen at −80°C, and later analyzed for viremia, antibody titer, IL-1β, tumor necrosis factor (**TNF**)-α, IL-12, interferon (**IFN**)-γ, IL-10, and haptoglobin (**Hp**).

Measurement of Viremia and PRRSV-Specific Antibody
--------------------------------------------------

Serum samples from pigs were tested by qRT-PCR method for measurement of viremia as previously described ([@bib2]). The viral concentrations were measured in triplicate in the serum samples collected before PRRSV inoculation (−28 and 0 DPI) and after PRRSV inoculation (7, 21, and 35 DPI). Quantification of the sample viral concentrations was calculated and expressed as numbers of cycle threshold.

Serum antibodies against PRRSV were measured in duplicate by a commercial ELISA kit following the procedures described by the manufacturer (IDEXX, Westbrook, ME). The ELISA sample to positive (**S/P**) ratio was calculated from each serum sample of the infected pigs. Pigs with an S/P ratio of 0.4 or greater were classified as PRRSV-positive.

Analyses of Cytokines and Haptoglobin in Serum
----------------------------------------------

Serum samples were assayed in duplicate with commercial porcine ELISA kits following the protocols provided by the manufacturers. Standards of known recombinant porcine cytokine and Hp concentrations were used to make standard curves. The ELISA kits used for quantification of cytokines and Hp were specific for IL-1β, IFN-γ (Invitrogen, Grand Island, NY), TNF-α, IL-12, IL-10 (R & D Systems, Minneapolis, MN), and Hp (GenWay Biotech, Inc., San Diego, CA). The serum samples were analyzed at 1:2 and 1:10,000 dilutions for cytokines and Hp, respectively. The intra-assay coefficients of variation for IL-1β, TNF-α, IL-12, IFN-γ, IL-10, and Hp were 4.5, 5.2, 3.4, 4.4, 3.3, and 2.7%, respectively. The inter-assay CV for TNF-α, IL-1β, IFN-γ, IL-12, IL-10, and Hp were 7.1, 6.4, 6.8, 6.0, 5.8, and 6.2%, respectively. The results were expressed in picograms or micrograms per milliliter based on a standard curve for cytokines and Hp, respectively.

Statistical Analysis
--------------------

Data were analyzed as an RCBD with a 2 × 2 factorial treatment arrangement by ANOVA using the MIXED procedure (SAS Inst. Inc., Cary, NC). A pig was considered an experimental unit for all measurements. For pig performance, the model included effects of ACT, PRRSV, and ACT × PRRSV interaction. Fixed effects were ACT and PRRSV, and random effects were initial-weight block. For viremia and antibody titers, data were analyzed within the infected pigs only because no PRRSV-specific antibodies and viruses were detected in sham-inoculated pigs. For RT, cytokines, and Hp, data were analyzed as repeated measures on each individual pig. The model included effects of ACT, PRRSV, day, and their interactions. Treatment differences were compared using the least squares means with a Tukey adjustment. Treatment effects were considered significant at *P* \< 0.05, whereas a trend for a treatment effect was noted when *P* \< 0.10.

RESULTS
=======

Growth Performance
------------------

Before PRRSV inoculation, pigs fed ACT had the same growth rate (280 vs. 267 ± 18) as those fed the control (*P* = 0.589). Similarly, dietary ACT did not affect ADFI (388 vs. 420 ± 27) as compared with the control (*P* = 0.399). There was no difference (*P* = 0.127) in G:F between the ACT diet and the control (732 vs. 663 ± 40).

After PRRSV inoculation, infection by PRRSV decreased (*P* \< 0.001) ADG, ADFI, and G:F during 0 to 14 DPI as compared with the sham control ([Table 2](#tbl2){ref-type="table"}). The ADG and ADFI of infected pigs were also lower from 14 to 28 DPI than those uninfected (*P* \< 0.001), but there were no effects of ACT (*P* = 0.547), PRRSV (*P* = 0.950), or their interaction (*P* = 0.259) on G:F during this period. From 28 to 42 DPI, infected pigs still grew slower (*P* = 0.002) and tended to have a decreased G:F (*P* = 0.052) than uninfected pigs. During the same period, the ACT × PRRSV interaction was significant for G:F (*P* = 0.042), suggesting that dietary ACT increased G:F in challenged pigs (*P* = 0.009). In addition, the diet with ACT did not affect ADG (*P* = 0.450), but decreased ADFI in pigs from 28 to 42 DPI (*P* = 0.047) as compared with the diet without ACT. Over a 6-wk challenge, infection with PRRSV reduced ADG (*P* \< 0.001), ADFI (*P* \< 0.001), and G:F (*P* = 0.004) in inoculated pigs as compared with the sham control. Diets supplemented with ACT tended to reduce ADFI (*P* = 0.072) and to increase G:F (*P* = 0.073) in pigs as compared with those without ACT.

###### 

Effect of mannan oligosaccharide (Actigen; ACT)^1^ and porcine reproductive and respiratory syndrome virus (PRRSV)^2^ on pig performance after PRRSV infection

                                      Treatment^4^          *P*-value                                 
  ------------------------------ --- -------------- ------ ----------- ------ ----- ------- --------- -------
  0 to 14 d after inoculation                                                                         
      ADG, g                      8       674        693       258      288    33    0.491   \<0.001   0.852
      ADFI, g                     8       1035       954       563      616    54    0.789   \<0.001   0.217
      G:F, g/kg                   8       663        730       454      453    43    0.445   \<0.001   0.433
  d 14 to 28 after inoculation                                                                        
      ADG, g                      8       713        709       495      477    30    0.650   \<0.001   0.708
      ADFI, g                     8       1281       1317      957      828    75    0.550   \<0.001   0.312
      G:F, g/kg                   8       567        549       529      583    31    0.547    0.950    0.259
  d 28 to 42 after inoculation                                                                        
      ADG, g                      8       950        925       661      756    44    0.450    0.002    0.216
      ADFI, g                     8       1963       1775     1855      1538   125   0.047    0.266    0.570
      G:F, g/kg                   8       486        526       357      508    26    0.003    0.052    0.042
  d 0 to 42 after inoculation                                                                         
      ADG, g                      8       779        776       479      509    24    0.588   \<0.001   0.488
      ADFI, g                     8       1427       1349     1127      994    52    0.072   \<0.001   0.602
      G:F, g/kg                   8       572        602       460      515    22    0.073    0.004    0.580

^1^Pigs were fed ACT (Actigen, Alltech, Inc., Nicholasville, KY) diets for 8 wk starting at weaning; after 2 wk of 8-wk feeding, pigs were challenged with PRRSV.

^2^Pigs were challenged with PRRSV at 5 wk of age.

^3^A pig was an experimental unit; each treatment had 8 pigs except ICON (7 pigs, 1 pig euthanized at 18 d postinfection).

^4^CON: uninfected control-fed pigs; ACT: uninfected ACT-fed pigs; ICON: infected control-fed pigs; IACT: infected ACT-fed pigs.

Clinical Signs
--------------

After inoculation, infected pigs first showed signs of sluggishness and loss of appetite beginning 2 to 3 DPI followed by increased RT. Respiratory symptoms such as coughing were not detected, but 1 pig from the infected control treatment was culled at 18 DPI due to difficult breathing and severe BW loss. The RT of infected pigs peaked at 3 DPI (40.3 vs. 39.7 ± 0.08°C), remained high until 10 DPI (40.2 vs. 39.7 ± 0.08°C), and returned to normal at 14 DPI (39.9 vs. 39.9 ± 0.06°C) as compared with sham controls ([Figure 1](#fig1){ref-type="fig"}). There was no ACT × PRRSV interaction for the febrile responses in pigs (*P* = 0.879). The PRRSV infection increased RT in inoculated pigs at 3, 7, and 10 DPI as compared with the sham control (*P* \< 0.001). The ACT × day interaction was not significant for RT. During the experimental period, pigs fed ACT also had a greater RT than those fed the control regardless of PRRSV (*P* = 0.045). All sham-inoculated pigs showed no clinical signs and remained healthy during the course of the experiment.

![Rectal temperature (RT) of pigs fed control or mannan oligosaccharide (Actigen; ACT, Alltech, Inc., Nicholasville, KY) diets with or without infection of porcine reproductive and respiratory syndrome virus (PRRSV). There was no ACT × PRRSV interaction for the febrile response in pigs. The PRRSV infection increased the RT in inoculated pigs at Days 3, 7, and 10 postinoculation as compared with the sham control (*P* \< 0.001). Pigs fed ACT also had a greater RT than those fed the control regardless of PRRSV (*P* = 0.045). Values were means; pooled SEM = 0.046. A pig was an experimental unit; each treatment had 8 pigs except ICON (7 pigs, 1 pig euthanized at 18 d postinfection). CON: uninfected control-fed pigs; ACT: uninfected ACT-fed pigs; ICON: infected control-fed pigs; IACT: infected ACT-fed pigs. \*\*\**P* \< 0.001.](2784fig1){#fig1}

Viremia and Antibody Titer
--------------------------

The serological and qRT-PCR tests were used to verify that our PRRSV challenge model was effective. Both tests confirmed that all serum samples collected from pigs at −28 DPI and 0 DPI (right before PRRSV inoculation) were PRRSV-negative. After PRRSV challenge, all pigs inoculated with PRRSV were PRRSV-positive and all those not inoculated with PRRSV were PRRSV-negative. All PRRSV-inoculated pigs remained viremic throughout the experiment, except that there were 3 PRRSV-negative pigs detected at 35 DPI (1 from the infected control treatment and 2 from the infected ACT treatment). The average viremic concentrations of pigs at 7, 21, and 35 DPI are presented as cycle threshold, which is inverse to the viremic concentration ([Figure 2A](#fig2){ref-type="fig"}). The cycle threshold values of infected pigs ranged from 14.4 to 22.4 at 7 DPI, 22.4 to 31.5 at 21 DPI, and 22.1 to 37.9 at 35 DPI suggesting gradual clearance of the virus from serum. Dietary ACT did not affect the viremic concentration in infected pigs at 7 (*P* = 0.768), 21 (*P* = 0.548), and 35 (*P* = 0.789) DPI. All pigs that were not inoculated with PRRSV remained PRRSV-free throughout the experiment.

![(A) Viremic concentration and (B) antibody titer in control- or mannan oligosaccharide \[Actigen, ACT (Alltech, Inc., Nicholasville, KY)\]-fed pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV). The antibody titer is presented as sample to positive control (S/P) ratios and viremic concentration as cycle threshold (Ct) values of all infected pigs. The Ct values presented are inversely related to virus concentrations. The antibody response of pigs to PRRSV was found negative (S/P \< 0.4) at 7 d postinoculation and positive at 21 and 35 DPI. Dietary ACT did not affect the antibody titer at 21 DPI (*P* = 0.139), but increased it at 35 DPI (*P* = 0.042). Dietary ACT did not affect the viremic concentrations of infected pigs throughout the experimental period. Values were means ± pooled SEM. A pig was an experimental unit; each treatment had 8 pigs except ICON (7 pigs, 1 pig euthanized at 18 d postinfection). ICON: infected control-fed pigs; IACT: infected ACT-fed pigs. \**P* \< 0.05.](2784fig2){#fig2}

The antibody titer presented as S/P ratios was measured at 7, 21, and 35 DPI ([Figure 2B](#fig2){ref-type="fig"}). An S/P ratio \< 0.4 was considered negative. The antibody response to PRRSV was found negative at 7 DPI and positive at 21 and 35 DPI. Dietary ACT did not affect (*P* = 0.139) the antibody titer of infected pigs at 21 DPI as compared with the control (S/P ratio: 1.5 vs. 1.2 ± 0.15). However, infected pigs fed the ACT diet had a greater antibody titer (*P* = 0.042) than those fed the control diet at 35 DPI (S/P ratio: 1.3 vs. 0.9 ± 0.12).

Serum Cytokines and Acute-Phase Protein
---------------------------------------

**IL-1β and TNF-α**. The infection with PRRSV increased (*P* \< 0.001) serum concentrations of IL-1β and TNF-α in infected pigs as compared with the sham control, but this pattern did not hold in the noninfected pigs ([Figure 3](#fig3){ref-type="fig"}). Diets supplemented with ACT increased IL-1β concentrations (*P* = 0.019) and tended to decrease TNF-α concentrations (*P* = 0.058) in pigs as compared with those not supplemented with ACT. The ACT × PRRSV interaction was found significant for IL-1β only (*P* = 0.016), indicating that infected pigs fed ACT had a greater IL-1β concentration than those fed the control (*P* = 0.006). Serum concentrations of IL-1β and TNF-α changed over time (*P* \< 0.001). Concentrations of IL-1β and TNF-α increased to a sharp peak at 14 DPI and then declined, but remained elevated until 42 or 28 DPI, respectively.

![(A) Serum IL-1β and (B) tumor necrosis factor (TNF)-α concentrations in pigs fed control or mannan oligosaccharide (Actigen; ACT, Alltech, Inc., Nicholasville, KY) diets with or without porcine reproductive and respiratory syndrome virus (PRRSV) infection. The concentrations of IL-1β and TNF-α of infected pigs were greater than those of uninfected ones (*P* \< 0.001). Dietary ACT increased the IL-1β concentration (*P* = 0.019), but tended to decrease the TNF-α concentration (*P* = 0.058) in pigs as compared with the control diet. There was an ACT × PRRSV interaction for IL-1β (*P* = 0.016), indicating that infected pigs fed the diet with ACT had a greater IL-1β concentration than those fed the diet without ACT (*P* = 0.006). There were also significant effects of day or interaction of day × PRRSV on IL-1β and TNF-α (*P* \< 0.001). Values were means; pooled SEM were 1.8 and 6.6 pg/mL for IL-1β and TNF-α, respectively. A pig was an experimental unit; each treatment had 8 pigs except ICON (7 pigs, 1 pig euthanized at 18 d postinfection). CON: uninfected control-fed pigs; ACT: uninfected ACT-fed pigs; ICON: infected control-fed pigs; IACT: infected ACT-fed pigs. †*P* \< 0.1; \**P* \< 0.05; \*\**P* \< 0.01.](2784fig3){#fig3}

**IL-12 and IFN-γ**. The PRRSV infection increased (*P* \< 0.001) serum concentrations of IL-12 and IFN-γ in pigs as compared with the sham control ([Figure 4](#fig4){ref-type="fig"}). There were no main effects of ACT on IL-12 (*P* = 0.766) and IFN-γ (*P* = 0.928). The ACT × PRRSV interaction was significant for IL-12 only (*P* = 0.026), suggesting that ACT increased the IL-12 concentration in infected pigs as compared with the control (*P* = 0.048). Serum concentrations of IL-12 and IFN-γ changed over time (*P* \< 0.001). These cytokines sharply reached their greatest concentrations at 7 DPI (IFN-γ) and 14 DPI (IL-12) and declined afterward, but remained increased until 42 DPI.

![(A) Serum IL-12 and (B) interferon (IFN)-γ concentrations in pigs fed control or mannan oligosaccharide (Actigen; ACT, Alltech, Inc., Nicholasville, KY) diets with or without porcine reproductive and respiratory syndrome virus (PRRSV) infection. The IFN-γ and IL-12 concentrations of infected pigs were greater than those of uninfected ones (*P* \< 0.001). There were no effects of diet on either cytokine. There was an ACT × PRRSV interaction (*P* = 0.026) for IL-12 only, indicating that infected pigs fed ACT had a greater concentration of IL-12 than those fed the control (*P* = 0.048). There were also significant effects of day or interaction of day x PRRSV on IFN-γ and IL-12 (*P* \< 0.001). Values were means; pooled SEM were 33.4 and 1.6 pg/mL for IL-12 and IFN-γ, respectively. A pig was an experimental unit; each treatment had 8 pigs except ICON (7 pigs, 1 pig euthanized at 18 d postinfection). CON: uninfected control-fed pigs; ACT: uninfected ACT-fed pigs; ICON: infected control-fed pigs; IACT: infected ACT-fed pigs. \**P* \< 0.05.](2784fig4){#fig4}

**IL-10 and Hp**. Serum concentrations of IL-10 and Hp were greater (*P* \< 0.001) in infected pigs than in sham controls ([Figure 5](#fig5){ref-type="fig"}). There were no main effects of ACT on IL-10 (*P* = 0.147) and Hp (*P* = 0.479). The ACT ×PRRSV interaction tended to be significant for IL-10 (*P* = 0.088) and was significant for Hp (*P* = 0.047). Infected pigs fed ACT tended to have a greater concentration of Hp than those fed the control (*P* = 0.058). Serum concentrations of IL-10 and Hp changed over time (*P* \< 0.001). The IL-10 and Hp increased more slowly before declining, and the peaks were less sharp as compared with the other inflammatory mediators.

![(A) Serum IL-10 and (B) Haptoglobin (Hp) concentrations in pigs fed control or mannan oligosaccharide (Actigen; ACT, Alltech, Inc., Nicholasville, KY) diets with or without porcine reproductive and respiratory syndrome virus (PRRSV) infection. Infection with PRRSV increased the serum concentrations of IL-10 and Hp in infected pigs (*P* \< 0.001). The ACT × PRRSV interaction tended to be significant for IL-10 (*P* = 0.088), but was significant for Hp (*P* = 0.047). There were also significant effects of day or interaction of day × PRRSV on IL-10 and Hp (*P* \< 0.001). Values were means; pooled SEM were 4.7 pg/mL and 142.5 μg/mL for IL-10 and Hp, respectively. A pig was an experimental unit; each treatment had 8 pigs except ICON (7 pigs, 1 pig euthanized at 18 d postinfection). CON: uninfected control-fed pigs; ACT: uninfected ACT-fed pigs; ICON: infected control-fed pigs; IACT: infected ACT-fed pigs. †*P* \< 0.1; \**P* \< 0.05; \*\*\**P* \< 0.001.](2784fig5){#fig5}

DISCUSSION
==========

Porcine reproductive and respiratory syndrome virus imposes a substantial loss to swine producers not only in the United States, but also other parts of the world ([@bib23]; [@bib5]). It weakens innate immune response at the early stage of infection and reduces the ineffective adaptive immunity during the persistent phase of PRRSV ([@bib21]; [@bib37]). These impacts of PRRSV bring about decreased productivity and possibly increase in susceptibility to other infections ([@bib34]; [@bib7]). Thus, use of multiple strategies to prevent or alleviate the adverse effects of PRRSV on pig performance and health is definitely needed.

Diets supplemented with MOS have been shown to modulate innate and adaptive immune responses in animals. They altered serum cytokine secretions and increased phagocytic activity of porcine macrophages, blood leukocytes, and serum immunoglobulin concentrations ([@bib31]; [@bib3]; [@bib2]). However, different MOS products extracted from the yeast cell wall may possess diverse immunoregulatory properties because each fraction differs in structural characteristics and proportions of functional carbohydrates ([@bib42]; [@bib1]; [@bib32]). Therefore, we examined the possibility of feeding ACT aimed at alleviating the negative effects of PRRSV infection on pig performance and improving the immune status of the pigs.

Infection with PRRSV reduced loss of appetite and depressed performance. In our experiment, anorexia occurred as early as 2 to 3 DPI and infected pigs showed signs of sluggishness. [@bib8] demonstrated that feeding time and activity of PRRSV-infected pigs started to decrease at 1 DPI and remained decreased until the end of the experiment (14 DPI). [@bib35] showed that PRRSV decreased ADFI beginning 3 DPI and throughout a 12-d experimental period. We found that the ADFI and ADG of infected pigs were greatly reduced during 0 to 28 DPI. However, from 28 to 42 DPI, the ADFI of infected pigs recovered to near normal (91% of the control), whereas the ADG of infected pigs was still substantially affected, with a reduction of 24%. These data suggest that retarded growth of pigs due to PRRSV infection results from not only the reduced feed intake, but also increased nutrient needs for the immune defense processes of the host. It was further observed that feeding ACT ameliorated the adverse effect of PRRSV on feed use. Infected pigs fed ACT had a better G:F during 28 to 42 DPI than those fed the control. In the present experiment, ACT also enhanced PRRSV-specific antibodies in infected pigs at 35 DPI. These combined improvements may be an indicator of efficient redirection of nutrient use for both growth and host defense processes during the chronic phase of infection. Improved feed efficiency in PRRSV-infected pigs consuming MOS was also documented previously ([@bib2]). It should also be noted that the ACT-reduced ADFI contributed to the improved G:F in pigs consuming ACT. Our result was consistent with the previous meta-analysis of MOS (Alltech, Inc., Nicholasville, KY), which showed that the improvements in G:F of pigs in most studies were resulted from the MOS-induced reductions of ADFI ([@bib19]). Together, these data suggest that ACT fed to pigs may alter metabolic changes leading to the reduced ADFI without compromising ADG.

Further, PRRSV caused a febrile response peaking at 3 DPI and returning to normal at 14 DPI. Other researchers also observed a similar fever response pattern ([@bib33]; [@bib6]). Activation of the immune system by PRRSV triggers secretions of inflammatory cytokines such as IL-1β, IL-6, and TNF-α that are most responsible for fever. Mild but prolonged fever is often a typical response to infections of a North American PRRSV strain. Depending on PRRSV strain and challenge dose, body temperature of infected pigs may remain sporadically elevated up to 14 or 28 DPI ([@bib34]; [@bib15]). It is worthy of note that during the experimental period, ACT slightly increased the RT of the pigs from 39.7 to 39.8°C regardless of PRRSV. This implies that feeding ACT might have induced changes in physiological and metabolic processes, which would contribute to the adjustment of body temperature. The effect of ACT on body temperature may, to a certain extent, be associated with ACT-induced activity of immune cells which perhaps helps the immune system stay alert, but not over-stimulated. Thus, further research on this aspect is required.

The diet with ACT boosted PRRSV-specific antibodies in infected pigs as compared with the diet without ACT. After exposure to PRRSV, specific antibodies may be detectable as early as 5 to 10 DPI ([@bib21]; [@bib4]). However, antibodies which appear during the early postinfection period are not efficient at neutralizing PRRSV, and therefore do not provide protection against the infection ([@bib21]; [@bib14]). Serum antibodies that neutralize PRRSV have been reported to arise about 21 to 28 DPI or later time points ([@bib13]; [@bib18]). In our experiment, the increased anti-PRRSV antibody response induced by ACT at 35 DPI may importantly contribute to the protection against PRRSV infection. The appearance of neutralizing antibodies is slow and lasts for only a few months, but good correlations between the appearance of neutralizing antibodies and clearance or prevention of viremia have been reported ([@bib41]; [@bib25]; [@bib14]). Although no clear effect of ACT on viremia was observed, ACT enhanced the adaptive immune response at the time which neutralizing antibodies are expected to appear in the circulation and consequently may confer a certain degree of protection. During this period, the improved G:F observed in infected pigs consuming ACT is likely to be associated with the increased antibody titer and numerically less ADFI. Therefore, the effect of ACT on total and neutralizing antibody concentrations and viremia should be examined for longer postinfection periods to further explore this potential benefit of ACT.

Increased concentrations of IL-1β were observed in pigs fed ACT. The PRRSV-induced IL-1β started to rise as early as 3 DPI and remained greater than that of uninfected pigs until 42 DPI. Interleukin-1β is one of the innate cytokines produced earliest after pigs are challenged with PRRSV, and its serum concentration is observed elevated up to 42 DPI ([@bib7]; [@bib12]; [@bib16]). It was assumed that IL-1β, together with other cytokines, could have an effect on viral persistence ([@bib16]). These data imply that IL-1β may play an important role during the early as well as subsequent stages of infection. Indeed, IL-1β is capable of promoting T-cell proliferation and B-cell maturation and multiplication. Infection with PRRSV elicits a weak production of pro-inflammatory cytokines which diminishes the ability of the host to efficiently mount subsequent immune responses ([@bib21]; [@bib17]). Hence, ACT-mediated upregulation of IL-1β protein in infected pigs may favorably raise the innate immunity against PRRSV.

Infection with PRRSV enhanced production of circulating T helper 1 (**Th1**)-associated cytokines including IL-12, IFN-γ, and TNF-α. Among these cytokines, infected pigs fed ACT had a greater IL-12 concentration than those fed the control. During infection, IL-12 enhances the killing activity of natural killer cells and induces IFN-γ production in natural killer and T cells ([@bib39]). Also, IL-12 plays a critical role in development of naive T cells to IFN-γ-secreting Th1 cells, which participate in cellular immunity ([@bib10]). Although ACT enhanced IL-12 in infected pigs, it did not affect the serum IFN-γ concentration. This suggests that there are multiple components of the immune system, apart from IL-12, influencing the activation of IFN-γ-secreting cells as well as production and release of IFN-γ into peripheral blood. Indeed, IFN-γ production is mediated via IL-18 and produced by different types of immune cells involved in not only early innate response but also the subsequent antigen-specific adaptive immunity ([@bib22]; [@bib30]). Consistent with earlier reports ([@bib40]; [@bib15]), our results indicated that IFN-γ was detectable soon after PRRSV infection and its serum concentration was low, but continued to be elevated for a couple of weeks postinfection. In regards to TNF-α, its serum concentration began to increase at 3 DPI and decreased to normal after 28 DPI. These data indicate the involvement of this cytokine in regulation of inflammation during acute and chronic phase responses. Other researchers also found increased concentrations of serum TNF-α as early as 3 to 7 DPI ([@bib12]; [@bib20]; [@bib2]). In general, feeding ACT to infected pigs may fortify the cell-mediated immunity as ACT is associated with the increased concentrations of IL-12 in infected pigs throughout the experimental period.

Release of serum anti-inflammatory mediators, IL-10 and Hp appears to be responsive to PRRSV-induced inflammation. Increased concentrations of IL-10 and Hp occurred later than the innate and Th1-associated cytokines. The IL-10 and Hp concentrations declined toward the end of the experiment, implying that the inflammatory process seems to be repressed. The increase in IL-10 of infected pigs may be dependent on the inflammation intensity caused by PRRSV. [@bib2] found elevated concentrations of IL-10 at 7 DPI. In another study, serum IL-10 increased at 33 DPI, peaked at 38 DPI, and diminished to the pre-infection concentrations ([@bib38]). Interleukin-10 is secreted to suppress inflammation through blocking activation of immune cells and synthesis of pro-inflammatory cytokines ([@bib26]). It is also capable of stimulating B cell maturation and antibody production. Consequently, production of IL-10 and other anti-inflammatory molecules is essential to regulate a harmony between protection and immunopathology. Increased IL-10 and PRRSV-specific antibodies, accompanied by decreased IL-12, after acute phase suggest that ACT aids in shifting from Th1 to T helper 2 (**Th2**) immune responses toward the end of the experiment. In addition, Hp, a type-2 acute phase protein has a strong response to PRRSV and often remains increased for several weeks postinfection before returning to normal ([@bib27]; [@bib9]). Cytokines such as TNF-α, IL-1β, and IL-6 induce hepatocyte-produced Hp. The rise of Hp appears to coincide with the increased IL-10. Acute phase proteins including Hp may provide a feedback mechanism by suppressing pro-inflammatory cytokine production ([@bib28]). Therefore, ACT-mediated increases of IL-10 and Hp in infected pigs during the chronic phase of PRRSV are likely to be crucial in enhancement of acquired immunity and suppression of inflammatory responses.

In summary, feeding ACT to weanling pigs alters the pattern of the immune responses of the pigs to a PRRSV infection during the course of study. Dietary ACT increases serum concentrations of inflammatory mediators that are important in boosting innate and cell-mediated immunity. Further, diets supplemented with ACT potentially mitigate negative impacts of PRRSV through enhanced PRRSV-specific antibodies. Feeding ACT is also efficacious in improving nutrient utilization in pigs infected with PRRSV. However, it should be noted that although not causing any adverse effects, feeding ACT slightly increases the body temperature of the pigs. To maximize use of ACT in diets, its effects on growth and immune response in pigs subjected to other pathogens require further examination, as commercially-reared pigs are frequently exposed to multiple pathogens including PRRSV.
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